nitroquine has been researched along with pam 1392 in 2 studies
| Studies (nitroquine) | Trials (nitroquine) | Recent Studies (post-2010) (nitroquine) | Studies (pam 1392) | Trials (pam 1392) | Recent Studies (post-2010) (pam 1392) |
|---|---|---|---|---|---|
| 18 | 1 | 2 | 8 | 0 | 0 |
| Protein | Taxonomy | nitroquine (IC50) | pam 1392 (IC50) |
|---|---|---|---|
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0182 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, JY; Hansch, C; Jow, PY | 1 |
| Elslager, EF; Johnson, JL; Werbel, LM | 1 |
2 other study(ies) available for nitroquine and pam 1392
| Article | Year |
|---|---|
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
Topics: Animals; Antimalarials; Escherichia coli; Folic Acid Antagonists; Mathematics; Mice; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Streptococcus; Structure-Activity Relationship | 1977 |
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
Topics: Animals; Antimalarials; Antineoplastic Agents; Bacteria; Drug Resistance; Folic Acid Antagonists; Haplorhini; Leukemia L1210; Leukemia P388; Mice; Plasmodium falciparum; Quinazolines; Trimetrexate | 1983 |